Skip to content
DefDex

Federal award

CYTOSORBENTS MEDICAL INC

W81XWH21C0045

ContractSBIR/STTR SR2

Obligated and Ceiling

Obligated (net)
$1,499,987.16
Ceiling (potential value, not spending)
$1,499,987.16
Current value
$1,499,987.16
Gross positive obligations
$1,499,987.16

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
CYTOSORBENTS MEDICAL INC · LSF2KFUSY4K7
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
CYTOSORBENTS MEDICAL INC · LSF2KFUSY4K7
Awarding agency
Department of War · sub-agency 97DH · office HT9425
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
AN11 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Industry (NAICS)
541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PIID
W81XWH21C0045
Award type code
D
Actions
6 · Apr 19, 2021 to Jun 5, 2024
Why it is listed
gross positive obligations of $100k or more (contracts); SBIR/STTR award

Open this award on USAspending →

Action History6

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 5, 2024FY2024P00005B$0.00
—
Feb 7, 2023FY2023P00004B$0.00
—
Sep 14, 2022FY2022P00003M$0.00
—
Jul 29, 2021FY2021P00002B$0.00
—
Jul 14, 2021FY2021P00001B$0.00
—
Apr 19, 2021FY20210—$1,499,987.16
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.